• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Upcoming dvm360 Conferences
Resources
CBD in Pets
CE Requirements by State
Contests
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
Veterinary Heroes
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Novartis WNV antibody gains conditional license

October 1, 2003

Novartis Animal Vaccines, Inc. has received USDA conditional license for West Nile Virus Antibody (Equine Origin) to help control the disease caused by the West Nile Virus.

Novartis Animal Vaccines, Inc. has received USDA conditional license for West Nile Virus Antibody (Equine Origin) to help control the disease caused by the West Nile Virus. The company says it is the only antibody product to carry such a claim. When it comes to caring for horses that have the West Nile Virus, veterinarians options have been limited, says Richard Harland, DVM, director of research and development for Novartis Animal Vaccines, Inc. Novartis has responded to this urgent need by developing a product that works against the virus.West Nile Virus Antibody is available from licensed veterinarians and is administered intravenously. Cornell University conducted a neutralizing index study that demonstrated the ability of the West Nile Virus Antibody to neutralize the West Nile Virus. Based on the study, researchers concluded there is a reasonable expectation of efficacy when the West Nile Virus Antibody is administered to horses that have been exposed to the virus. Field safety trials conducted to bring the product to market demonstrated West Nile Virus Antibody is safe when used according to label directions, says Harland. A complimentary expert roundtable discussion audio program is available by calling (800) 454-3424 ext. 339 and asking for New strategies for managing the West Nile Virus CD-ROM.

For fastest response call (913) 451-2708 or visit the Web site at www.livestock.novartis.com.

Related Content:

Products
 Vetstoria releases its Fill Rate platform
Vetstoria releases its Fill Rate platform
Communicating the importance of genetic screening
Communicating the importance of genetic screening
Study reveals Zymox Otic Plus is beneficial and effective
Study reveals Zymox Otic Plus is beneficial and effective

Advertisement

Latest News

The four-letter word to why you're burning out and feeling unproductive

Merck Manuals recognizes importance of One Health concept

Topical therapy and immunotherapy can save time and frustration with dermatology cases

Texas Tech appoints new faculty member with passion for animal agriculture

View More Latest News
Advertisement